| 1 |
Nyarubamba RF, Silumbwe A, Jacobs C, Maritim P, Mdoe P, Zulu JM. Assessment of contextual factors shaping delivery and uptake of isoniazid preventive therapy among people living with HIV in Dar es salaam, Tanzania. BMC Infect Dis 2022;22:884. [PMID: 36434517 DOI: 10.1186/s12879-022-07867-5] [Reference Citation Analysis]
|
| 2 |
Naburi HE, Mujinja P, Kilewo C, Biberfeld G, Bärnighausen T, Manji K, Lyatuu G, Urrio R, Zethraeus N, Orsini N, Ekström AM. Health care costs associated with clinic visits for prevention of mother-to-child transmission of HIV in Dar es Salaam, Tanzania. Medicine (Baltimore) 2021;100:e27828. [PMID: 34797311 DOI: 10.1097/MD.0000000000027828] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 3 |
Uppal A, Rahman S, Campbell JR, Oxlade O, Menzies D. Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis. PLoS Med 2021;18:e1003712. [PMID: 34520463 DOI: 10.1371/journal.pmed.1003712] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 4 |
Yaghoubi A, Salehabadi S, Abdeahad H, Hasanian SM, Avan A, Yousefi M, Jamehdar SA, Ferns GA, Khazaei M, Soleimanpour S. Tuberculosis, human immunodeficiency viruses and TB/HIV co-infection in pregnant women: A meta-analysis. Clinical Epidemiology and Global Health 2020;8:1312-20. [DOI: 10.1016/j.cegh.2020.05.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 5 |
Hunter OF, Kyesi F, Ahluwalia AK, Daffé ZN, Munseri P, von Reyn CF, Adams LV. Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania. BMC Infect Dis 2020;20:738. [PMID: 33028260 DOI: 10.1186/s12879-020-05471-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 6 |
Durovni B, Cavalcante S. Preventive therapy for HIV-associated tuberculosis. Curr Opin HIV AIDS 2018;13:507-11. [PMID: 30286041 DOI: 10.1097/COH.0000000000000504] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 7 |
Zeng Y, Luo M, Chen J, He H, Deng X, Xie S, Fang Y. An economic evaluation of the current measles vaccination program: A case study in Zhejiang Province, east China. Vaccine 2019;37:3071-7. [PMID: 31040084 DOI: 10.1016/j.vaccine.2019.04.057] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Kendall EA, Azman AS, Maartens G, Boulle A, Wilkinson RJ, Dowdy DW, Rangaka MX. Projected population-wide impact of antiretroviral therapy-linked isoniazid preventive therapy in a high-burden setting. AIDS 2019;33:525-36. [PMID: 30325773 DOI: 10.1097/QAD.0000000000002053] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Yirdaw KD, Teklu AM, Mamuye AT, Zewdu S. Breakthrough tuberculosis disease among people with HIV - Should we be worried? A retrospective longitudinal study. PLoS One 2019;14:e0211688. [PMID: 30716126 DOI: 10.1371/journal.pone.0211688] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
